
About 85% of all instances of lung cancer are non-small cell lung cancer (NSCLC), making it the most common kind of the disease. It happens when aberrant cells proliferate in the lungs and cause tumors to grow. Compared to small cell lung cancer (SCLC), non-small cell lung cancer (NSCLC) is typically less aggressive and grows and spreads more slowly.
There are many types of NSCLC, including-
Timely treatment of Non-Small Cell Lung Cancer (NSCLC) is essential for several reasons:
Respiratory Symptoms
Chest Symptoms
General Symptoms
Causes
Risk Factors
Precision medicine, which includes Next-Generation Sequencing (NGS) for genetic testing and individualised medicines, is helping to advance the treatment of Non-Small Cell Lung Cancer (NSCLC) in Malaysia. Immunotherapies and targeted medicines are improving treatment results. Furthermore, advancements such as AI-enhanced liquid biopsy are facilitating early identification and monitoring, demonstrating Malaysia's dedication to implementing modern technology for improved NSCLC care.
There are a few things you can do to lower your risk of developing Non-Small Cell Lung Cancer (NSCLC), particularly of the bladder, even if it is not always preventable:
Treatment options for NSCLC differ based on the type and stage of the disease and the patient's overall health. The following are a few current treatments:
Lobectomy: Elimination of a lung lobe. The most popular procedure for NSCLC in its early stages is this one.
Pneumonectomy: Removal of a lung in its whole. If the cancer is in an area of the lung where the entire organ needs to be removed, this procedure might be carried out.
Wedge Resection: This removes a little lung section with the tumor.
Segmentectomy: This is the Removal of a more prominent lung segment but not the entire lobe. Usually, this is applied to individuals with lung impairment or early-stage cancer.
Radiation Therapy: Treatments using high-energy rays to target cancer cells and reduce tumour size are known as radiation therapy. It may be used in combination with chemotherapy for Non-Small Cell Lung Cancer (NSCLC).
Targeted Therapy : Medication designed for particular forms of lung cancer is used in this treatment. Targeted therapy can locate and target specific cancer cells without endangering healthy cells.
Cost Start From USD 2000 - USD 10000Explore Options
Immunotherapy : This is typically advised for late-stage lung cancer, notably Stage IV NSCLC, as it triggers your body's immune system to target and eliminate cancer cells.
Cost Start From USD 15000 - USD 50000Explore Options
Chemotherapy : It uses medications that target lung cancer. It is among the most widely used therapies for NSCLC. Chemotherapy may be prescribed by your oncologist alone or in conjunction with other treatments.
Cost Start From USD 1500 - USD 3500Explore Options
Clinical Evaluation
Imaging Studies
Biopsy
Laboratory Tests
MediRehab (a chain of Rehab centres, part of MediGence) provides comprehensive rehabilitation services to support patients through Teleconsulations and online therapy sessions.
Lifestyle changes and modification
While lifestyle modifications like stress reduction, yoga, and meditation improve general well-being, dietary changes involving high-fiber meals, lean meats, and supplements boost nutrition. Long-term health is further enhanced by abstaining from alcohol and eating a balanced diet.
Speech and Swallowing Therapy
Patients with NSCLC may have trouble speaking or swallowing if the disease affects the mouth, throat, or digestive system. Speech therapists can help patients regain clarity in their speech and enhance their swallowing function.
Monitoring and follow-up
Schedule regular follow-up appointments with the oncologist to address complications, monitor recovery, and detect any signs of recurrence.
Depending on the circumstances, your doctor might recommend medication to help manage your symptoms and complement the course of treatment.









Kuala Lumpur, Malaysia
Sunway Medical Centre has initiated a comprehensive expansion plan close to its current hospital facility to enhance its ability to provide services to the global market. The new Cancer Radiosurgery Center and Nuclear Medicine Center, which will also house additional Centers of Excellence like the Digestive Health Center and Dialysis Center, marked the completion of Tower C's first phase in October 2016.

Kuala Lumpur, Malaysia
Prince Court is a private medical facility in the center of Kuala Lumpur that has 277 individual beds. Our dedication is to provide you with the best treatment possible from the time you arrive until you depart, healthier and happier. We are well-known for our top-notch facilities, cutting-edge technology, and friendly customer service.

Kuala Lumpur, Malaysia
Subang Jaya Medical Center is renowned for pioneering radiation oncology treatments and infrastructure in Malaysia. The hospital also has a state-of-the-art Cancer Radiosurgery Centre (CRC), which is fully furnished with the latest medical technology for cancer detection, monitoring, and treatment.
Opinion & Option
We submit the most accurate opinion and options from one or more countries for your review
Consult Privately
Consult with a certified specialist privately on our telemedicine platform even before you decide to travel
Logistics
We handle flights, visas, transfers, and accommodation—so you can focus on your health.
Recovery
Our In-house rehabilitation service packages to better your recovery and treatment outcome
In Malaysia, recovery times following therapy for non-small cell lung cancer (NSCLC) vary depending on the type of treatment, the features of the tumour, and the patient's health. Recovery from other therapies, such as chemotherapy or radiation, can take anything from a few weeks to several months, whereas recovery from surgery may take between 6 to 12 weeks.
In Malaysia, it is customary practice to get a second opinion. Many hospitals and oncologists are willing to assess cases and offer second opinions on treatment strategies. One can:
Regular follow-up visits are part of the post-treatment care for patients with non-small cell lung cancer (NSCLC) in Malaysia. These visits are used to assess treatment response, manage side effects, and detect recurrence. Additionally, patients receive lifestyle counseling, palliative care, and rehabilitation to enhance their quality of life.
Yes, even after a successful course of treatment, non-small cell lung cancer (NSCLC) might return. The type of treatment received, the patient's response to the treatment, and the stage of the cancer at diagnosis all affect the chance of recurrence.
The stage of diagnosis determines the prognosis for individuals with non-small cell lung cancer (NSCLC) in Malaysia; patients who are diagnosed early have higher survival rates. However, many cases are discovered at an advanced stage, which results in a decreased overall survival rate, usually about 11% over a five-year period.
About 10% of all malignancies in Malaysia are lung cancers, making them a major cause of cancer-related mortality. About 80% of these cases are Non-Small Cell Lung Cancer (NSCLC), with a 5-year relative survival rate of only 11%, since a large percentage of these cases are detected at advanced stages.
Malaysia is a cost-effective choice for those seeking treatment because it provides top-notch medical care at affordable costs compared to several Western nations.
Malaysia's healthcare system accepts patients from abroad and provides excellent NSCLS treatments at many clinics and hospitals.
Yes, many Malaysian hospitals offer in-person and online consultations to foreign patients who want a second opinion. You can get support by speaking with a medical tourism facilitator at MediGence to select the best doctor and facility. It provides specialised rehabilitation programs.